Pharmacological interventions on the catalytic activity of CA IX using a number of sulfonamide derivatives have disrupted the pH balance of cancer cells, leading to a reduction of primary tumour growth and inhibition of metastases formation1–5,.17 The gene discussed is CA9; the disease is cancer.